Internal medicine resident knowledge, attitudes, and barriers to naloxone prescription in hospital and clinic settings

Substance Abuse

Volumn 37, Issue 3, 2016, Pages 480-487

  Wilson, J Deanna ^a   Spicyn, Natalie ^a   Matson, Pamela ^a   Alvanzo, Anika ^a   Feldman, Leonard ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Drug overdose; medical education; naloxone

Indexed keywords

NALOXONE; NARCOTIC ANALGESIC AGENT;

ATTITUDE TO HEALTH; DRUG OVERDOSE; EDUCATION; FEMALE; HEALTH CARE DELIVERY; HUMAN; INTERNAL MEDICINE; MALE; MEDICAL EDUCATION; OPIATE ADDICTION; PROGRAM EVALUATION;

ANALGESICS, OPIOID; DRUG OVERDOSE; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HEALTH SERVICES ACCESSIBILITY; HUMANS; INTERNAL MEDICINE; INTERNSHIP AND RESIDENCY; MALE; NALOXONE; OPIOID-RELATED DISORDERS; PROGRAM EVALUATION;

EID: 84980047807     PISSN: 08897077     EISSN: 15470164     Source Type: Journal    
DOI: 10.1080/08897077.2016.1142921     Document Type: Article

References (45)

1. Centers for Disease Control. Prescription drug overdose. http://www.cdc.gov/drugoverdose/. Accessed June8, 2015.
2. K.Krisberg Fatal heroin overdoses on increase as use skyrockets:health officials battling opiate epidemic. Nations Health. 2014;44(4):1–10. http://thenationshealth.aphapublications.org/content/44/4/1.1. Accessed February17, 2015.
3. Centers for Disease Control. Policy impact:prescription painkiller overdose. http://www.cdc.gov/drugoverdose/pdf/policyimpact-prescriptionpainkillerod-a.pdf. Published 2011. Accessed July4, 2015.
4. L.E.Grau, T.C.Green, M.Torban, et al. Psychosocial and contextual correlates of opioid overdose risk among drug users in St. Petersburg, Russia. Harm Reduct J. 2009;4:6–17. doi:10.1186/1477-7517-6-17.
5. M.J.Milloy, N.Fairbairn, K.Hayashi, et al. Overdose experiences among injection drug users in Bangkok, Thailand. Harm Reduct J. 2010;13:7–9. doi:10.1186/1477-7517-7-9.
6. B.Sergeev, A.Karpets, A.Sarang, M.Tikhonov. Prevalence and circumstances of opiate overdose among injection drug users in the Russian Federation. J Urban Health. 2003;80:212–219. doi:10.1093/jurban/jtg024.
7. S.J1Strang, V.Manning, S.Mayet, et al. Overdose training and take-home naloxone for opiate users:prospective cohort study of impact on knowledge and attitudes and subsequent management of overdoses. Addiction. 2008;103:1648–1657. doi:10.1111/j.1360-0443.2008.02314.x.
8. K.A.Sporer Strategies for preventing heroin overdose. BMJ. 2003;326:442–444. doi:10.1136/bmj.326.7386.442.
9. D.M.Yealy, P.M.Paris, R.M.Kaplan, et al. The safety of pre-hospital naloxone administration by paramedics. Ann Emerg Med. 1990;19:902–905.
10. D.Kim, K.S.Irwin, K.Khoshnood. Expanded access to naloxone:options for critical response to the epidemic of opioid overdose mortality. Am J Public Health. 2009;99:402–407. doi:10.2105/AJPH.2008.136937.
11. E.W.Boyer Management of opioid analgesic overdose. N Engl J Med. 2012;367:146–155. doi:10.1056/NEJMra1202561.
12. E.Wheeler, P.J.Davidson, T.S.Jones, K.S.Irwin. Community-based opioid overdose prevention programs providing naloxone—United States, 2010. MMWR Morb Mortal Wkly Rep. 2012;61:101–105. http://www.cdc.gov/mmwr/preview/mmwrhtml/mm6106a1.htm?s_cid=mm6106a1_w. Accessed July3, 2015.
13. A.Walley, Z.Xuan, H.H.Hackman, et al. Opioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts:interrupted time series analysis. BMJ. 2013;346:1–12.
14. K.E.Tobin, S.G.Sherman, P.Beilenson, C.Welsh, C.A.Latkin. Evaluation of the Staying Alive programme:training injection drug users to properly administer naloxone and save lives. Int J Drug Policy. 2009;20:131–136.
15. T.M.Hammett, S.Phan, J.Gaggin, et al. Pharmacies as providers of expanded health services for people who inject drugs:a review of laws, policies and barriers in six countries. BMC Health Serv Res. 2014;14:1–11.
16. National Institute on Drug Abuse. Nationwide trends. https://www.drugabuse.gov/publications/drugfacts/nationwide-trends. Updated June 2015. Accessed October25, 2015.
17. E.Swenson-Britt, G.Carrougher, B.W.Martin, M.Brackley. Project HOPE:changing care delivery for the substance abuse patient. Clin Nurse Spec. 2000;14:92–100.
18. Maryland Department of Health and Mental Hygiene. Hospital utilization of deaths in 2013. http://bha.dhmh.maryland.gov/OVERDOSE_PREVENTION/SitePages/Data%20and%20Reports.aspx. Published 2014. Accessed February17, 2015.
19. Survey Research Laboratory at University of Illinois Chicago. Missed Opportunity:National Survey of Primary Care Physicians and Patients on Substance Abuse. http://www.casacolumbia.org/addiction-research/reports/national-survey-primary-care-physicians-patients-substance-abuse. Published 2000. Accessed February18, 2015.
20. C.Holland Barriers to identification of Problem Alcohol and Drug Use:Results of Statewide Focus Groups [master's thesis]. Pittsburgh, PA:University of Pittsburgh School of Public Health; 2007. http://d-scholarship.pitt.edu/8828/1/HollandC_etd2007.pdf. Accessed July5, 2015.
21. A.S.Bohnert, M.Valenstein, M.J.Bair, et al. Association between opioid prescribing patterns and opioid overdose-related deaths. JAMA. 2011;305:1315–1321. doi:10.1001/jama.2011.370.
22. S.Bowman, J.Eiserman, L.Beletsky, S.Stancliff, R.D.Bruce. Reducing the health consequences of opioid addiction in primary care. Am J Med. 2013;126:565–571.
23. K.M.Dunn, K.W.Saunders, C.M.Rutter, et al. Opioid prescriptions for chronic pain and overdose. Ann Intern Med. 2010;152:85–92. doi:10.7326/0003-4819-152-2-201001190-00006.
24. A.J.Hall, J.E.Logan, R.L.Toblin, et al. Patterns of abuse among unintentional pharmaceutical overdose fatalities. JAMA. 2008;300:2613–2620.
25. United States Department of Health and Human Services. Addressing Prescription Drug Abuse in the United States. Current Activities and Future Opportunities. http://www.cdc.gov/drugoverdose/pdf/hhs_prescription_drug_abuse_report_09.2013.pdf. Published September 2013. Accessed July3, 2015.
26. American Medical Association. AMA adopts new policies at annual meeting. http://www.ama-assn.org/ama/pub/news/news/2012-06-19-ama-adopts-new-policies.page. Published 2012. Accessed February17, 2015.
27. American Public Health Association. Reducing opioid overdose through education and naloxone distribution. http://www.apha.org/policies-and-advocacy/public-health-policy-statements/policy-database/2014/07/16/13/08/reducing-opioid-overdose-through-education-and-naloxone-distribution. Published 2013. Accessed February17, 2015.
28. American Society of Addiction Medicine. Public Policy Statement on the Use of Naloxone for the Prevention of Drug Overdose Deaths. http://www.asam.org/docs/default-source/publicy-policy-statements/1naloxone-rev-8-14.pdf?sfvrsn=0. Published 2014. Accessed February17, 2015.
29. Maryland Department of Health and Mental Hygiene. “Dear Treatment Provider.” http://bha.dhmh.maryland.gov/OVERDOSE_PREVENTION/Documents/October2014%20Naloxone%20Expansion%20Letter_Treatment%20Provider.pdf. Published October 2014. Accessed February17, 2015.
30. L.Beletsky, R.Ruthazer, G.E.Macalino, J.D.Rich, L.Tan, S.Burris. Physicians' knowledge of and willingness to prescribe naloxone to reverse accidental opiate overdose:challenges and opportunities. J Urban Health. 2007;84:126–36.
31. C.Matheson, C.Pflanz-Sinclair, L.Aucott, et al. Reducing drug related deaths:a pre-implementation assessment of knowledge, barriers and enablers for naloxone distribution through general practice. BMC Fam Pract. 2014;15:12. doi:10.1186/1471-2296-15-12.
32. T.C.Green, S.E.Bowman, N.D.Zaller, M.Ray, P.Case, R.Heimer. Barriers to medical support for prescription naloxone as overdose antidote for lay responders. Subst Use Misuse. 2013;48:558–567. doi:10.3109/10826084.2013.787099.
33. N.Kirschner, J.Ginsburg, L.S.Sulmasy, Health and Public Policy Committee of the American College of Physicians. Prescription drug abuse:executive summary of a policy position paper from the American College of Physicians. Ann Intern Med. 2014;160:198–200. doi:10.7326/M13-2209.
34. D.Kim, K.S.Irwin, K.Khoshnood. Expanded access to naloxone:options for critical response to the epidemic of opioid overdose mortality. Am J Public Health. 2009;99:402–407.
35. J.H.Isaacson, M.Fleming, M.Kraus, R.Kahn, M.Mundt. A National survey of training in substance use disorders in residency programs. J Stud Alcohol. 2000;61:912–915.
36. Maryland Department of Health and Mental Hygiene. Maryland Opioid Overdose Prevention Plan. http://bha.dhmh.maryland.gov/OVERDOSE_PREVENTION/Documents/MarylandOpioidOverdosePreventionPlan2013%20(4).pdf. Published January 2013. Accessed October25, 2015.
37. P.O.Coffin, C.Fuller, L.Vadnai, S.Blaney, S.Galea, D.Vlahov. Preliminary evidence of health care providers support for naloxone prescription as overdose fatality prevention strategy in New York City. J Urban Health. 2003;80:288–290.
38. M.J.Van Wert, A.Gatewood, A.Andrada. Perceived barriers to prescribing naloxone to third parties as an overdose prevention strategy:a qualitative study of academic physician and medical student attitudes. Poster presented at 10th National Harm Reduction Conference; October23–26, 2014; Baltimore, Maryland.
39. Qualtrics. Qualtrics. Version 62232. Provo, UT:Qualtrics; 2015. www.Qualtrics.com.
40. StataCorp. Stata Statistical Software:Release 13. College Station, TX:StataCorp; 2013.
41. M.Dresser Hogan unveils plan to fight heroin. Baltimore Sun. February 24, 2015. http://www.baltimoresun.com/news/maryland/politics/bs-md-hogan-heroin-20150224-story.html. Accessed October24, 2015.
42. K.E.Tobin, S.G.Sherman, P.Beilenson, C.Welsh, C.A.Latkin. Evaluation of the Staying Alive programme:training injection drug users to properly administer naloxone and save lives. Int J Drug Policy. 2009;20:131–136. doi:10.1016/j.drugpo.2008.03.002.
43. S.G.Sherman, D.S.Gann, K.E.Tobin, C.A.Latkin, C.Welsh, P.Bielenson. “The life they save may be mine”:diffusion of overdose prevention information from a city sponsored programme. Int J Drug Policy. 2009;20:137–142. doi:10.1016/j.drugpo.2008.02.004.
44. R.P.Schwartz, J.Gryczynski, K.E.O'Grady, et al. Opioid agonist treatments and heroin overdose deaths in Baltimore, Maryland, 1995–2009. Am J Public Health. 2013;103:917–922. doi:10.2105/AJPH.2012.301049.
45. G.C.Alexander, S.Frattaroli, A.C.Gielen, eds. The Prescription Opioid Epidemic:An Evidence-Based Approach. Baltimore, MD:Johns Hopkins Bloomberg School of Public Health; 2015. http://www.jhsph.edu/research/centers-and-institutes/center-for-drug-safety-and-effectiveness/opioid-epidemic-town-hall-2015/2015-prescription-opioid-epidemic-report.pdf. Published November 2015. Accessed December14, 2015.